Clapham DE, Julius D, Montell C, Schultz G (December 2005). "International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels". Pharmacological Reviews. 57 (4): 427–450. doi:10.1124/pr.57.4.6. PMID16382100. S2CID17936350.
Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Högestätt ED, et al. (January 2004). "Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1". Nature. 427 (6971): 260–265. Bibcode:2004Natur.427..260J. doi:10.1038/nature02282. PMID14712238.
Baraldi PG, Preti D, Materazzi S, Geppetti P (July 2010). "Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents". Journal of Medicinal Chemistry. 53 (14): 5085–5107. doi:10.1021/jm100062h. PMID20356305.
Brône B, Peeters PJ, Marrannes R, Mercken M, Nuydens R, Meert T, et al. (September 2008). "Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor". Toxicology and Applied Pharmacology. 231 (2): 150–156. Bibcode:2008ToxAP.231..150B. doi:10.1016/j.taap.2008.04.005. PMID18501939.
Valencia-Montoya WA, Liénard MA, Rosser N, Calonje M, Salzman S, Tsai CC, et al. (December 2025). "Infrared radiation is an ancient pollination signal". Science. 390 (6778): 1164–1170. doi:10.1126/science.adz1728. PMID41379967.
Boonen B, Startek JB, Talavera K (2016-01-01). "Chemical Activation of Sensory TRP Channels". Taste and Smell. Topics in Medicinal Chemistry. Vol. 23. Springer Berlin Heidelberg. pp. 73–113. doi:10.1007/7355_2015_98. ISBN978-3-319-48925-4.
Gijsen HJ, Berthelot D, Zaja M, Brône B, Geuens I, Mercken M (October 2010). "Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel". Journal of Medicinal Chemistry. 53 (19): 7011–7020. doi:10.1021/jm100477n. PMID20806939.
Pace-Asciak CR (April 2015). "Pathophysiology of the hepoxilins". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851 (4): 383–396. doi:10.1016/j.bbalip.2014.09.007. PMID25240838.
Maher SA, Dubuis ED, Belvisi MG (June 2011). "G-protein coupled receptors regulating cough". Current Opinion in Pharmacology. 11 (3): 248–253. doi:10.1016/j.coph.2011.06.005. PMID21727026.
Grilo A, Sáez-Rosas MP, Santos-Morano J, Sánchez E, Moreno-Rey C, Real LM, et al. (January 2011). "Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough". Pharmacogenetics and Genomics. 21 (1): 10–17. doi:10.1097/FPC.0b013e328341041c. PMID21052031. S2CID22282464.
Herz JM, Kesicki E, Tian J, Zhu MX, Thomsen WJ (2016). A Novel Class of Potent, Allosteric TRPA1 Antagonists Reverse Hyperalgesia in Multiple Rat Models of Neuropathic Pain. Experimental Biology 2016 Meeting. Vol. 30, art. 927.3. doi:10.1096/fasebj.30.1_supplement.927.3.
Pryde DC, Marron B, West CG, Reister S, Amato G, Yoger K, et al. (2016-11-08). "The discovery of a potent series of carboxamide TRPA1 antagonists". MedChemComm. 7 (11): 2145–2158. doi:10.1039/C6MD00387G.
Qu Q, Xuan W, Fan GH (January 2015). "Roles of resolvins in the resolution of acute inflammation". Cell Biology International. 39 (1): 3–22. doi:10.1002/cbin.10345. PMID25052386. S2CID10160642.
Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Högestätt ED, et al. (January 2004). "Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1". Nature. 427 (6971): 260–265. Bibcode:2004Natur.427..260J. doi:10.1038/nature02282. PMID14712238.
Brône B, Peeters PJ, Marrannes R, Mercken M, Nuydens R, Meert T, et al. (September 2008). "Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor". Toxicology and Applied Pharmacology. 231 (2): 150–156. Bibcode:2008ToxAP.231..150B. doi:10.1016/j.taap.2008.04.005. PMID18501939.
Clapham DE, Julius D, Montell C, Schultz G (December 2005). "International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels". Pharmacological Reviews. 57 (4): 427–450. doi:10.1124/pr.57.4.6. PMID16382100. S2CID17936350.
Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Högestätt ED, et al. (January 2004). "Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1". Nature. 427 (6971): 260–265. Bibcode:2004Natur.427..260J. doi:10.1038/nature02282. PMID14712238.
Baraldi PG, Preti D, Materazzi S, Geppetti P (July 2010). "Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents". Journal of Medicinal Chemistry. 53 (14): 5085–5107. doi:10.1021/jm100062h. PMID20356305.
Brône B, Peeters PJ, Marrannes R, Mercken M, Nuydens R, Meert T, et al. (September 2008). "Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor". Toxicology and Applied Pharmacology. 231 (2): 150–156. Bibcode:2008ToxAP.231..150B. doi:10.1016/j.taap.2008.04.005. PMID18501939.
Valencia-Montoya WA, Liénard MA, Rosser N, Calonje M, Salzman S, Tsai CC, et al. (December 2025). "Infrared radiation is an ancient pollination signal". Science. 390 (6778): 1164–1170. doi:10.1126/science.adz1728. PMID41379967.
Gijsen HJ, Berthelot D, Zaja M, Brône B, Geuens I, Mercken M (October 2010). "Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel". Journal of Medicinal Chemistry. 53 (19): 7011–7020. doi:10.1021/jm100477n. PMID20806939.
Pace-Asciak CR (April 2015). "Pathophysiology of the hepoxilins". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851 (4): 383–396. doi:10.1016/j.bbalip.2014.09.007. PMID25240838.
Maher SA, Dubuis ED, Belvisi MG (June 2011). "G-protein coupled receptors regulating cough". Current Opinion in Pharmacology. 11 (3): 248–253. doi:10.1016/j.coph.2011.06.005. PMID21727026.
Grilo A, Sáez-Rosas MP, Santos-Morano J, Sánchez E, Moreno-Rey C, Real LM, et al. (January 2011). "Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough". Pharmacogenetics and Genomics. 21 (1): 10–17. doi:10.1097/FPC.0b013e328341041c. PMID21052031. S2CID22282464.
Qu Q, Xuan W, Fan GH (January 2015). "Roles of resolvins in the resolution of acute inflammation". Cell Biology International. 39 (1): 3–22. doi:10.1002/cbin.10345. PMID25052386. S2CID10160642.
Clapham DE, Julius D, Montell C, Schultz G (December 2005). "International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels". Pharmacological Reviews. 57 (4): 427–450. doi:10.1124/pr.57.4.6. PMID16382100. S2CID17936350.
Macpherson LJ, Dubin AE, Evans MJ, Marr F, Schultz PG, Cravatt BF, et al. (February 2007). "Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines". Nature. 445 (7127): 541–545. Bibcode:2007Natur.445..541M. doi:10.1038/nature05544. PMID17237762. S2CID4344572.
Grilo A, Sáez-Rosas MP, Santos-Morano J, Sánchez E, Moreno-Rey C, Real LM, et al. (January 2011). "Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough". Pharmacogenetics and Genomics. 21 (1): 10–17. doi:10.1097/FPC.0b013e328341041c. PMID21052031. S2CID22282464.
Qu Q, Xuan W, Fan GH (January 2015). "Roles of resolvins in the resolution of acute inflammation". Cell Biology International. 39 (1): 3–22. doi:10.1002/cbin.10345. PMID25052386. S2CID10160642.